Dec 142017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MI – Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C), today announced the appointment of Jeffrey Berkowitz, J.D.… => Read more

Esperion Therapeutics appoints Jeff Berkowitz to the Board of Directors

From:: Esperion Therapeutics appoints Jeff Berkowitz to the Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: